Skip to main content

Table 1 Baseline characteristics of the study groups (means ± SD)

From: Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration

Variable

T&E protocol (n = 54)

Fixed protocol (n = 72)

p-value

Gender (Male:Female)

43%:57%

36%:64%

0.3

Eye (Right:Left)

52%:48%

48%:52%

0.5

Patient age (years)

80 ± 7

81 ± 6

0.6

CNV type (1:2)

56%:44%

58%:42%

0.7

Phakic:Pseudophakic

27%:73%

13%:87%

0.9

BCVA (Log MAR)

0.61 ± 0.3

0.72 ± 0.3

0.09

CMT (μm)

371 ± 101

393 ± 116

0.5

  1. T&E: Treat and extend, CNV: Choroidal neovascularization, BCVA: Best corrected visual acuity, CMT: Central macular thickness
  2. p value refers to statistical differences between two groups